BCL2 and benign prostatic hyperplasia: As shown in Fig 5B and 5C, the expression of Bcl-2, which includes the anti-apoptotic factor upregulated and the pro-apoptotic factor Bax significantly (p < 0.001) downregulated in the BPH group, compared with the control group.